These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8267805)

  • 1. Monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus and newborn.
    Sacks DA; Nance SJ; Garratty G; Petrucha RA; Horenstein J; Fotheringham N
    Am J Perinatol; 1993 Nov; 10(6):428-31. PubMed ID: 8267805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional evaluation of erythrocytic antibodies by photometric detection of erythrophagocytosis in the monocyte monolayer assay].
    Cassens U; Garritsen HS; Sibrowski W; Holzgreve W
    Geburtshilfe Frauenheilkd; 1996 Jun; 56(6):297-300. PubMed ID: 8766487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The monocyte monolayer assay: a noninvasive technique for predicting the severity of in utero hemolysis.
    Larson PJ; Thorp JM; Miller RC; Hoffman M
    Am J Perinatol; 1995 May; 12(3):157-60. PubMed ID: 7612085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of severity of haemolytic disease of newborn by monocyte monolayer assay.
    Dhingra-Kumar N; Duguid JK; Bromilow IM
    Indian J Med Res; 1995 Aug; 102():71-6. PubMed ID: 8834817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte monolayer assay: an efficient noninvasive technique for predicting the severity of hemolytic disease of the newborn.
    Nance SJ; Nelson JM; Horenstein J; Arndt PA; Platt LD; Garratty G
    Am J Clin Pathol; 1989 Jul; 92(1):89-92. PubMed ID: 2750714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of anti-Jka alloimmunization.
    Franco A; Rossi K; Krugh D; O'Shaughnessy R
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prenatal diagnosis and prevention of hemolytic disease of newborn].
    Fischer K
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():64-9. PubMed ID: 8374293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Yta does not cause hemolytic disease of the newborn.
    Nugent CE; Gelinas JR; Judd WJ; Steiner EA
    Obstet Gynecol; 1992 May; 79(5 ( Pt 2)):872-3. PubMed ID: 1565392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies.
    Arndt PA; Garratty G
    Transfusion; 2004 Sep; 44(9):1273-81. PubMed ID: 15318848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic disease of the newborn caused by anti-Wright (anti-Wra): case report and review of literature.
    Squires A; Nasef N; Lin Y; Callum J; Khadawardi EM; Drolet C; Core D; Simmons B
    Neonatal Netw; 2012; 31(2):69-80. PubMed ID: 22397791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
    Wenk RE; Goldstein P; Felix JK
    Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemolytic disease of the newborn due to ABO incompatibility (author's transl)].
    Fischer K; Poschmann A; Grundmann A
    Z Geburtshilfe Perinatol; 1977 Aug; 181(4):227-40. PubMed ID: 410177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prediction of the severity of fetal erythroblastosis using the erythrocyte phagocytosis test and evaluating anti-Rh antibody titers and their levels by autoanalysis].
    Brojer E; Zupańska B; Lenkiewicz B; Góralski S; Lozińska D; Przybyszewska G; Seyfried H
    Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):249-52. PubMed ID: 2122424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemolytic disease of newborn infants caused by anti-Diego antibodies].
    Monestier M; Rigal D; Meyer F; Juron-Dupraz F; Baboin-Jaubert M; Marseglia GL
    Arch Fr Pediatr; 1984 Nov; 41(9):641-3. PubMed ID: 6542344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appearance of maternal anti-JK a antibody following intrauterine transfusions and amniocentesis.
    Simpson MB; Pryzbylik JA; Denham MA; Radcliffe JH
    Obstet Gynecol; 1978 Nov; 52(5):616-7. PubMed ID: 724181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical case of the month. Mild hemolytic disease of the newborn due to an anti-Wr(a) antibody].
    Keutgens A; Monfort M; Wagemans D; Van Cauwenberge JR; Gérard C
    Rev Med Liege; 2012; 67(7-8):403-6. PubMed ID: 22984759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte monolayer assay (MMA)--an efficient method for predicting the clinical significance of alloantibodies and the severity of hemolytic disease of the newborn.
    Garratty G
    Beitr Infusionsther; 1988; 21():236-9. PubMed ID: 2462981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.